Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs

被引:72
作者
Van den Mooter, Guy
Weuts, Ilse
De Ridder, Thomas
Blaton, Norbert
机构
[1] Katholieke Univ Leuven, Lab Farmacotechnol & Biofarmacie, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Lab Analyt Chem & Med Fysicochem, B-3000 Louvain, Belgium
关键词
itraconazole; solid dispersions; Inutec SP1; spray drying; hot-stage extrusion;
D O I
10.1016/j.ijpharm.2006.02.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid dispersions made up of itraconazole and Inutec SP1, a new polymeric surfactant, were prepared by spray drying and hot-stage extrusion. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRD) were used to evaluate the miscibility of the components of the dispersions, and dissolution experiments were performed in simulated gastric fluid without pepsin (SGF(sp)) to evaluate the pharmaceutical performance of itraconazole from the solid dispersions. DSC analysis showed that the solid dispersions are phase separated systems made up of glassy and crystalline itraconazole and amorphous Inutec SP1. The amount of crystalline drug substance was higher in the dispersions prepared by hot-stage extrusion and was clearly a function of the drug concentration. Since no crystallinity could be detected by XRD points to the,fact that the crystallites formed are very small in size. Despite the presence of glassy and crystalline clusters, the dissolution properties of the solid dispersions were significantly improved in comparison to pure itraconazole (glassy or crystalline) or physical mixtures with Inutec SP1. This study proves the potential of the new polymeric surfactant as a carrier in the formulation of solid dispersions for poorly soluble drugs. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 18 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
BOOTEN K, 2003, HOUSEHOLD PERS CARE, V1, P26
[3]   Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system [J].
Dannenfelser, RM ;
He, H ;
Joshi, Y ;
Bateman, S ;
Serajuddin, ATM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) :1165-1175
[4]   ITRACONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1989, 37 (03) :310-344
[5]  
HEBBETTE C, 2002, THESIS K U LEUVEN
[6]   Improving drug solubility for oral delivery using solid dispersions [J].
Leuner, C ;
Dressman, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :47-60
[7]   Characterization of the Interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4, and 7 [J].
Peeters, J ;
Neeskens, P ;
Tollenaere, JP ;
Van Remoortere, P ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (06) :1414-1422
[8]   Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs [J].
Serajuddin, ATM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (10) :1058-1066
[9]   Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion [J].
Six, K ;
Daems, T ;
de Hoon, J ;
Van Hecken, A ;
Depre, M ;
Bouche, MP ;
Prinsen, P ;
Verreck, G ;
Peeters, J ;
Brewster, ME ;
Van den Mooter, G .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (2-3) :179-186
[10]   Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers [J].
Six, K ;
Verreck, G ;
Peeters, J ;
Brewster, M ;
Van den Mooter, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (01) :124-131